- Filed
- Mar 31, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 24, 2026 | 56.53M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 25.11M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 592.48K sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $20.58M |
| Capex | FY 2025 · Dec 31, 2025 | $88K |
| Capex | FY 2025 · Dec 31, 2024 | $342K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$20.77M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$8.77M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $39.49M |
| Cash And Equivalents restated | FY 2025 · Dec 31, 2024 | $7.62M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $406.49M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $16.2M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $4.59M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $4.29M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $4.77M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $4.61M |
| Current Assets | FY 2025 · Dec 31, 2025 | $42.36M |
| Current Assets | FY 2025 · Dec 31, 2024 | $16.47M |
| Total Assets | FY 2025 · Dec 31, 2025 | $411.16M |
| Total Assets | FY 2025 · Dec 31, 2024 | $20.64M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$5.96 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$19.36 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$5.96 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$19.36 |
| Net Income | FY 2025 · Dec 31, 2025 | −$148.48M |
| Net Income | FY 2025 · Dec 31, 2024 | −$10.33M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$36.44M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$11.64M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $3.89M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $224K |
| Revenue | FY 2025 · Dec 31, 2025 | $12.78M |
| Revenue | FY 2025 · Dec 31, 2024 | $895K |
| Short Term Investments | FY 2025 · Dec 31, 2024 | $4.91M |